Vivaldi Biosciences' Series A Round

Vivaldi Biosciences raised a round of funding on December 05, 2008. Investors include Alexandria Venture Investments.

Developing genetically modified vaccines to protect against common seasonal influenza and emergent pandemic influenza. Formed to commercialize patented vaccine and virus technologies developed at the…

Articles about Vivaldi Biosciences' Series A Round: